(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway

Por Shen, Yi, Jiang, Ting, Wang, Rongsheng, He, Shijun, Guo, Mengru, Zuo, Jianping, He, Dongyi
Publicado no BMC Complement Altern Med (2015)